AMRZ
AMRZBasic MaterialsNASDAQBuilding Materials · Last scanned Sep 8, 2026
Scan Results
Daily timeframeAMRZ operates in the Building Materials space. Amrize AG engages in the provision of various building solutions for infrastructure, commercial, and residential construction markets in North America and Canada. At a $23.97B market cap, AMRZ ranks as a large-cap company within basic materials. It operates through two segments, Building Materials and Building Envelope.
Market Cap
$23.97B
Beta
—
P/E (TTM)
19.65
P/E (Fwd)
14.62
EPS (TTM)
$2.23
EPS (Fwd)
$3.00
ROE
9.7%
ROA
5.0%
Cash
$729.0M
Total Debt
$7.09B
Free CF
$1.13B
52W Change
-19.4%
Annual Financials
Cash vs Debt
Where AMRZ stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, AMRZ finished 19.26% below its 150-day moving average ($53.22) and 19.14% below its 200-day moving average ($53.14). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is AMRZ overbought or oversold?
At the September 3, 2026 close, AMRZ's RSI(14) was 29.9, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $729.0M in cash, though total debt stands at $7.09B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $1.13B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 9.7% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 5.0% is on the lower side, which is common in asset-heavy industries. Revenue has been uneven over recent years, ranging from $10.73B to $11.81B.
AMRZ carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence AMRZ's trajectory.